The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors.

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

The 3 new color additives are Galdieria extract blue, butterfly pea flower extract, and calcium phosphate. HealthDay News — The US Food and Drug Administration announced the approval of 3 new color ...

The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of hypertension in adults, to lower blood pressure.

New epinephrine nasal spray dosage approved for pediatrics; FDA agree to review semaglutide for weight management; wearable defibrillator cleared to prevent sudden cardiac arrest; a low dose ...

Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.

The prescription device is a wearable belt that includes a motor designed to transmit low amplitude, high frequency vibration to the spine and hips.

In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination.